MCDANIEL RAYMOND W - 19 Feb 2026 Form 4 Insider Report for RAYMOND JAMES FINANCIAL INC (RJF)

Reporting relationship: Director
Issuer ticker: RJF
Reported as of: 19 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 Feb 2026, 15:56:30 UTC
Prior SEC filing: 16 Jan 2026
Next SEC filing: 24 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Raymond W. McDaniel by Jonathan J. Doyle as Attorney-in-Fact

Key filing fact

MCDANIEL RAYMOND W filed Form 4 for RAYMOND JAMES FINANCIAL INC (RJF) on 23 Feb 2026.

Key facts

This page summarizes MCDANIEL RAYMOND W's Form 4 filing for RAYMOND JAMES FINANCIAL INC (RJF).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 23 Feb 2026, 15:56.

Change

Previous filing in this sequence was filed on 16 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001195306 Primary reporting owner

MCDANIEL RAYMOND W

Relationship: Director
Address: 880 CARILLON PARKWAY, ST. PETERSBURG
Signature: /s/ Raymond W. McDaniel by Jonathan J. Doyle as Attorney-in-Fact
Signature date: 23 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RJF transaction

Common Stock

Award

Transaction value: $0
Shares: +1,303
Change %: +27%
Price: $0.000000
Shares after: 6,113
Date: 19 Feb 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Consists of a grant of Deferred Restricted Stock Units ("DRSUs") as part of compensation for service on the registrant's Board of Directors. Upon vesting, the DRSUs convert to the right to receive shares of common stock on a one-to-one basis, together with accrued cash in lieu of dividends. The DRSUs vest at the date of the next succeeding annual shareholders meeting following the grant date, but no later than March 15 of the calendar year following grant. Pursuant to an irrevocable election by the reporting person, settlement of the DRSUs will be deferred following vesting until the date the reporting person terminates his or her service on the Board of Directors.

Footnote F2

Includes DRSUs.

SEC remarks

This Form 4 reports the acquisition by the reporting person of DRSUs resulting from an annual grant to the registrant's non-executive directors.